In vivo and in vitro study on potential combination therapy of COL-3 and tamoxifen in breast cancer: a pilot study
Master's
Saved in:
Main Author: | ZHENG LIN |
---|---|
Other Authors: | PHARMACY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/17537 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Pre-clinical studies on pharmacokinetics and pharmacodynamics of col-3, a matrix metalloproteinase inhibitor: Single agent and in combination with doxorubicin
by: LI JING
Published: (2019) -
Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
by: Khan, S., et al.
Published: (2021) -
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore
by: Shih, V., et al.
Published: (2014) -
Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin
by: Li, J., et al.
Published: (2011) -
Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin
by: Li, J., et al.
Published: (2014)